References
- Anonymous. (2009). Annual Report of the US Organ Procurement andTransplantation Network and the Science Registry of Transplant Recipients:Transplantation data 1999-2008. Department of health and human services, Rockville, MD.
- Anonymous. (2010). Eurotransplant International Foundation. Annual report 2010. Osterlee, A., Ramel, A. Central Office. Leiden. The Netherlands.
- Archdeacon, P., Chan, M., Neuland, C., Velidedeoglu, E., Meyer, J., Tracy, L., Cavaille-Coll, M., Bala, S., Hemandez, A., Albrecht, R. (2011). Summary of FDA Antibody-Mediated Rejection Workshop. Amer. J. Transplant., 11, 896-906.
- Bartel, G., Wahrmann, M., Regel, H. (2010). Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation. Amer. J. Transplant., 10, 2033-2041.
- Billen, E., Christiaans, M., van denBerg-Loonen, E. (2009). Clinical relevance of Luminex donor-specific crossmatches: Data from 165 renal transplants. Tiss. Antigens, 74 (3), 205-211.
- Bruce, V., Suranyi, M. (1995). Understanding rejection. In: The Handbook ofTransplant Immunology. Wood, K. (ed.) MedSci, Oxford, pp. 113-133.
- Burns, J., Cornell, L., Perry, D., Pollinger, H., Gloor, J. (2008). Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Amer. J. Transplant., 8, 2684-2694.
- Cecka, J. (2011). Current methodologies for detection sensitization to HLA antigens. Curr. Opin. Organ Transplant., 16, 398-411.
- Chapmen, J., Taylor, C., Ting, A., Morris, P. (1986). Hypereacute rejection of renal allograft in the presence of anti-HLA Cw5 antibody. Transplantation, 42, 91-95.
- Claas, F., Rahmel, A., Doxiadis, I. (2009). Enhanced kidney allocation to highly sentized patients by the acceptable mismatch program. Transplantation, 88, 447-453
- Clatworthy, M. R. (2011). Targeting B cells and antibody in transplantation. Amer. J. Transplant., 11, 1359-1367.
- Collins, A., Scheeberger, E., Pascual, M. (1999). Compliment activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J. Amer. Soc, Nephol., 10, 2208-2215.
- Colvin, R. (2007). Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J. Amer. Soc. Nephrol., 18, 1046-1056.
- Danovitch, G. (ed.). (2010). Handbook of Kidney Transplantation. Philadelphia: Wolter Kluwer. 471 pp.
- Dragun, D., Muller, D., Brasen, M. (2005). Angiotensin II Type I-receptor activating antibodies in renal allograft rejection. New Engl. J. Med., 352, 558-569.
- Einecke, G., Sis, B., Reeve, J., Mengel, M., Husain, S. (2009). Antibody- mediated microcirculation injury is the major cause of late kidney transplant failure. Amer. J. Transplant., 9, 2520-2509.
- Everly, M., Terasaki, P., Trivedt, H. (2012). Durability of antibody removal following proteasome inhibitor-based therapy. Transplantation, 93, 572-577.
- Fehr, T., Gaspert, A. (2012). Antibody-mediated kidney allograft rejection: Therapeutic options and their experimental rationale. Transplant. Int., 25, 623-632.
- Feucht, H, Schneeberger, H, Hillebrand, G. (1993). Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int., 43, 1333-1341.
- Fuggle, S., Martin, S. (2008). Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation, 86, 384-389.
- Gaston, R., Cecka, J., Kasiske, B. (2010). Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation, 90, 68-76
- Gebel, H., Bray, R. (2000). Sensitization and sensitivity: Defining the unsensitized patient. Transplantation, 69, 1370-1374.
- Gloor, J., Sethi, S., Stegall, M., Cosio, F., Rea, D. (2007). Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Amer. J. Transplant., 7, 2124-2130.
- Halloran, P., de Freitas, D., Einecke, G., Solez, K., Ritchie, A. (2010). An integrated view of molecular changes, histopathology and outcomes in kidney transplant Amer. J. Transplant., 10, 2223-2230.
- Halloran, P., Wadgymar, A., Ritchie, S., Falk, J., Solez, K., Srinivasa, N. (1990). The significance of anti-class I antibody response. I. Clinical and pathologic features of anti-class I- mediated rejection. Transplantation, 49, 85-89.
- Hricik, D. (ed.). (2011). Primer of Transplantation. Willey-Blackwell, UK. 307 pp.
- Kamar, N., Milioto, O., Puissant-Librano, B., Esposito, L., Pierre, M. C., Mohamed, A. O., Lavayssière, L., Cointault, O., Ribes, D., Cardeau, I., Nogier, M. B., Durand, D., Abbal, M., Blancher, A., Rostaing, L. (2010). Incidence and predictive factors for infections disease after rituximab therapy in kidney-transplant patients. Amer. J. Transplant., 10, 89-98.
- Lefaucheur, C., Suberbielle-Boissel, C., Hill, G. (2009). Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib. Nephrol., 162, 1-11.
- Lefaucheur, C., Loupy, A., Hill, G. (2010). Preexisiting donor-specific HLA antibodies predict outcome in kidney transplantation. J. Amer. Soc. Nephrol., 21, 1398-1407.
- Lefaucheur, C., Antonie, C., Suberbielle, C., Glotz, D. (2011). Mastering the risk of HLA antibodies in kidney transplantation: An algorithm based on pretransplant single-antigen flow bead techniques. Amer. J. Transplant., 11, 1592-1598.
- Loupy, A., Suberbielle-Boissel, C., Hill, G., Nochy, D. (2009). Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Amer. J. Transplant., 9, 2561-2570.
- Loupy, A., Hill, G., Suberbielle, C. (2011). Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with performed donor-specific antibodies (DSA). Amer. J. Transplant., 11, 56-67.
- Mao, Q., Terasaki, P., Cai, J. (2007). Extremely high association between appearance of HLA antobodies and failure of kidney graft in a five-year longitudinal study. Amer. J. Transplant., 7, 864-875.
- Marrari, M., Duquesnoy, R. (2010). Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transplant. Immunol., 22, 105-111.
- McDonald, S., Russ, G., Campbell, S., Chadban, S. (2007). Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome. Amer. J. Transplant., 7, 1201-1208.
- Mengel, M., Sis, B., Haas, M., Colvin, R., Halloran, P., Racusen, L. (2012). Banff 2011 meeting report: New concepts in antibody-mediated rejection. Amer. J. Transplant., 12, 563-570.
- Mengel, M., Husain, S., Hidalgo, L., Sis, B. (2012). Phenotypes of antibody- mediated rejection in organ transplant. Transplant. Int., 25, 611-622.
- Montgomery, R. (2010). Renal transplantation across HLA and ABO antibody barriers: Integrating paired donation into desensitization protocols. Amer. J. Transplant., 10, 449-458.
- Morath, C., Opelz, G., Zeier, M., Susal, C. (2012). Prevention of antibody- mediated kidney transplant rejection. Transplant. Int., 25, 633-645.
- Muthukumar, T., Mueller, F., Anglicheau, D., Sharma, V., Ding, R., Suthanthiran, M. (2011). Intragraft microRNA expression signatures of interstitial fibrosis and tubular athrophy of human renal allograft. Amer. J. Transplant., 10, 291-298.
- Navkivel, B., Alexander, S. (2010). Mechanisms of disease: Rejection of kidney allograft. New Engl. J. Med., 363, 1451-1461.
- Poduval, R., Kadambi, P., Josephson, M., Cohn, R., Harald, R. (2005). Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation, 79, 228-235.
- Roelen, D., Doxiadis, I., Claas, F. (2012). Detection and clinical relevance of donor specific HLA antibodies: A matter of debate. Transplant. Int., 25, 604-610.
- Schnaidt, M., Weinstock, C., Jurisic, M., Schmidt-Horch, B., Ender, A, Wernet, D. (2011). HLA antibody specification using single-antigen beads-a technical solution for the prozone effect. Transplantation, 92, 510-515.
- Sellares, J., de Frietas, D., Mengel, M., Reeve, J., Matas, A., Halloran, P. (2012). Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Amer. J. Transplant., 12, 388-399.
- Shehata, N., Palda, V., Meyer, R. (2010). The use of immunoglobulin therapy for patients undergoing solid organ transplantation: An evidence-based practice guideline. Transfuse Med. Rev., 24 (suppl.1) S7.
- Sis, B., Jhangri, G., Riopel, J., Chang, D., de Freitas, D. G., Hidalgo, L., Mengel, M., Matas, A., Halloran, P. F. (2012). A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplant. Amer. J. Transplant., 12, 1168-1179.
- Stegall, M., Gloor, J., Winters, J., Moore, S., Degoey, S. (2006). A comparison of plasmapheresis versus high dose IVIG desensitization in renal allograft recipients with high levels of donor-specific alloantibody. Amer. J. Transplant., 6, 346-353.
- Stegall, M., Dean, P., Gloor, J. (2009). Mechanisms of alloantibody production to sensitized renal allograft recipients. Amer. J. Transplant., 9, 998-1006.
- Susal, C., Dohler, B., Opelz, G. (2009). Presensitized kidney graft recipient with HLA class I and II antibodies are at increased risk for graft failure: A collaborative transplant study report. Hum. Immunol., 70, 59-67.
- Terasaki, P. (2003). Humoral theory of transplantation. Amer. J. Transplant., 3, 665-673.
- Tripkov, K., Cambell, P., Pazderka, F., Cocfield, S., Solez, K., Halloran, P. (1996). Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplantation, 61, 1586-1591.
- Vaidya, S., Partlow, D., Susskind, B., Noor, M., Barnes, T., Gugliuzza, K. (2006). Prediction of cross-match outcome in highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation, 82, 1524-1532.
- Venetz, J., Pascual, M. (2007). New treatments for acute humoral rejection in kidney allograft. Expert Opin. Investing. Drugs., 16, 625-632.
- Wiebe, C., Gibson, I., Blydt-Hansen, T., Karpinski, M., Ho, J. (2012). Evolution and clinical pathologic correlation of de novo donor-specific HLA antibody post kidney transplant. Amer. J. Transplant., 12, 1157-1167.
- Zachary, A., Montgomery, R., Ratner, L., Racusen, L. (2003). Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation, 76, 1519-1525.
- Zachary, A., Lucas, D., Detrick, B., Leffel, M. (2009). Naturally occurring interference in Luminex assay for HLA-specific antibodies: Characteristics and resolution. Hum, Immunol., 70, 496-502.
- Zeevi, A., Girnita, A., Duquesnoy, R. (2006). HLA antibody analysis: Sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol. Res., 36, 255-264.
- Zou, Y., Stasny, P., Susal, C., Dohler, B., Opelz, G. (2007). Antibodies against MICA antigens and kidney transplant rejection. New Engl. J. Med.,357, 1293-3000.